Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_assertion type Assertion NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_head.
- NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_assertion description "[Forty-two (81%) of the patients were classified using FAB criteria for blood and bone marrow morphology: refractory anemia (RA), 11; refractory anemia with ringed sideroblasts (RARS), four; refractory anemia with excess blasts (RAEB), 12; chronic myelomonocytic leukemia (CMML), three; refractory anemia with excess blasts in transformation (RAEB-T), 12 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_provenance.
- NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_assertion evidence source_evidence_literature NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_provenance.
- NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_assertion SIO_000772 11960342 NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_provenance.
- NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_assertion wasDerivedFrom befree-20140225 NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_provenance.
- NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_assertion wasGeneratedBy ECO_0000203 NP610558.RAfVzqXvczPAOgQsC3Pkg5aXNOax7mEf6cyALs9MTJP9o130_provenance.